Braidwell »

Engene Holdings shares owned by Braidwell

Quarter-by-quarter ownership of Engene Holdings (ENGN) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Braidwell

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 2.3M 6.83

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
VR Adviser
Kynam Capital Management
Blue Owl Capital Holdings
Cormorant Asset Management
Braidwell
Deep Track Capital
Perceptive Advisors
Point72 Asset Management
Frazier Life Sciences Management
Franklin Resources
Adage Capital Partners GP
Sr One Capital Management
MPM Oncology Impact Management
Omega Fund Management

View all funds holding Engene Holdings